ACTG Publications

TitleAuthorsDateJournalIssueVolume
Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164.Sax, Paul E ; Sloan, Caroline E ; Schackman, Bruce R ; Grant, Philip M ; Rong, Jian ; Zolopa, Andrew R ; Powderly, William ; Losina, Elena ; Freedberg, Kenneth A ; Cepac US And Actg A5164 Investigators2010 Sep-OctHIV Clin Trials511
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.Zolopa, Andrew ; Andersen, Janet ; Powderly, William ; Sanchez, Alejandro ; Sanne, Ian ; Suckow, Carol ; Hogg, Evelyn ; Komarow, Lauren2009PLoS One54
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).Andrade, Adriana ; Guedj, Jeremie ; Rosenkranz, Susan L ; Lu, Darlene ; Mellors, John ; Kuritzkes, Daniel R ; Perelson, Alan S ; Ribeiro, Ruy M ; ACTG A5249s protocol team2015 Nov 28AIDS1829
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.Grant, Philip M ; Tierney, Camlin ; Budhathoki, Chakra ; Daar, Eric S ; Sax, Paul E ; Collier, Ann C ; Fischl, Margaret A ; Zolopa, Andrew R ; Balamane, Maya ; Katzenstein, David2013 Nov-DecHIV Clin Trials614
Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data.Simpson, Kit N ; Dietz, Birgitta ; Baran, Robert W ; Garren, Kevin W ; Riddler, Sharon A ; Bhor, Menaka ; Haubrich, Richard H2011Cost Eff Resour Alloc9
Educational attainment and response to HAART during initial therapy for HIV-1 infection.Marc, Linda G ; Testa, Marcia A ; Walker, Alexander M ; Robbins, Gregroy K ; Shafer, Robert W ; Anderson, Norman B ; Berkman, Lisa F ; ACTG Data Analysis Concept Sheet Study Team2007 AugJ Psychosom Res263
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.Podany, Anthony T ; Bao, Yajing ; Swindells, Susan ; Chaisson, Richard E ; Andersen, Janet W ; Mwelase, Thando ; Supparatpinyo, Khuanchai ; Mohapi, Lerato ; Gupta, Amita ; Benson, Constance A ; Kim, Peter ; Fletcher, Courtney V ; AIDS Clinical Trials Group A5279 Study Team2015 Oct 15Clin Infect Dis861
Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts.Ribaudo, Heather J ; Kuritzkes, Daniel R ; Lalama, Christina M ; Schouten, Jeffrey T ; Schackman, Bruce R ; Acosta, Edward P ; Gulick, Roy M2008 Apr 1J Infect Dis7197
The effect of aging on T-regulatory cell frequency in HIV infection.Tenorio, Allan R ; Spritzler, John ; Martinson, Jeffrey ; Gichinga, Caroline N ; Pollard, Richard B ; Lederman, Michael M ; Kalayjian, Robert C ; Landay, Alan L2009 MarClin Immunol3130
The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation.Geng, Elvin H ; Kahn, James S ; Chang, Olivia C ; Hare, C Bradley ; Christopoulos, Katerina A ; Jones, Diane ; Petersen, Maya L ; Deeks, Steven G ; Havlir, Diane V ; Gandhi, Monica2011 NovClin Infect Dis1053
Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy.Stapleton, J T ; Bennett, K ; Bosch, R J ; Polgreen, P M ; Swindells, S2007 Nov-DecHIV Clin Trials68
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.Gandhi, Rajesh T ; Spritzler, John ; Chan, Ellen ; Asmuth, David M ; Rodriguez, Benigno ; Merigan, Thomas C ; Hirsch, Martin S ; Shafer, Robert W ; Robbins, Gregory K ; Pollard, Richard B ; ACTG 384 Team2006 Aug 1J Acquir Immune Defic Syndr442
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.Jacobson, Jeffrey M ; Bosinger, Steven E ; Kang, Minhee ; Belaunzaran-Zamudio, Pablo ; Matining, Roy M ; Wilson, Cara C ; Flexner, Charles ; Clagett, Brian ; Plants, Jill ; Read, Sarah ; Purdue, Lynette ; Myers, Laurie ; Boone, Linda ; Tebas, Pablo ; Kumar, Princy ; Clifford, David ; Douek, Daniel ; Silvestri, Guido ; Landay, Alan L ; Lede2016 JulAIDS Res Hum Retroviruses732
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.Acosta, Edward P ; Kendall, Michelle A ; Gerber, John G ; Alston-Smith, Beverly ; Koletar, Susan L ; Zolopa, Andrew R ; Agarwala, Sangeeta ; Child, Michael ; Bertz, Richard ; Hosey, Lara ; Haas, David W2007 SepAntimicrob Agents Chemother951
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.Ribaudo, Heather J ; Liu, Huan ; Schwab, Matthias ; Schaeffeler, Elke ; Eichelbaum, Michel ; Motsinger-Reif, Alison A ; Ritchie, Marylyn D ; Zanger, Ulrich M ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David ; Haas, David W2010 Sep 1J Infect Dis5202
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.Weinberg, Adriana ; Park, Jeong-Gun ; Bosch, Ronald ; Cho, Alice ; Livingston, Elizabeth ; Aweeka, Fran ; Cramer, Yoninah ; Watts, D Heather ; Luque, Amneris E ; Cohn, Susan E2016 Feb 1J Acquir Immune Defic Syndr271
Effect of early versus deferred antiretroviral therapy for HIV on survival.Kitahata, Mari M ; Gange, Stephen J ; Abraham, Alison G ; Merriman, Barry ; Saag, Michael S ; Justice, Amy C ; Hogg, Robert S ; Deeks, Steven G ; Eron, Joseph J ; Brooks, John T ; Rourke, Sean B ; Gill, M John ; Bosch, Ronald J ; Martin, Jeffrey N ; Klein, Marina B ; Jacobson, Lisa P ; Rodriguez, Benigno ; Sterling, Timothy R ; Kirk, Grego2009 Apr 30N Engl J Med18360
The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.Chew, Kara W ; Hua, Lei ; Bhattacharya, Debika ; Butt, Adeel A ; Bornfleth, Lorelei ; Chung, Raymond T ; Andersen, Janet W ; Currier, Judith S2014 DecOpen Forum Infect Dis31
Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.Twigg Iii, Homer L ; Weiden, Michael ; Valentine, Fred ; Schnizlein-Bick, Carol T ; Bassett, Roland ; Zheng, Lu ; Wheat, Joseph ; Day, Richard B ; Rominger, Helen ; Collman, Ronald G ; Fox, Lawrence ; Brizz, Barbara ; Dragavon, Joan ; Coombs, Robert W ; Bucy, R Pat ; AIDS Clinical Trials Group Protocol 723 Team2008 Jan 1J Infect Dis1197
Effect of HIV-1 infection on human DNA yield from saliva.Basham, Rebecca J ; Richardson, Danielle M ; Sutcliffe, Cara B ; Haas, David W2009 Jul-AugHIV Clin Trials410
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients.Bakshi, Rahul P ; Hamzeh, Fayez ; Frank, Ian ; Eron, Joseph J ; Bosch, Ronald J ; Rosenkranz, Susan L ; Cramer, Yoninah S ; Ussery, Michael ; Flexner, Charles2007 NovAIDS Res Hum Retroviruses1123
The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.Eron, Joseph J ; Bosch, Ronald J ; Bettendorf, Daniel ; Petch, Leslie ; Fiscus, Susan ; Frank, Ian ; Adult Clinical Trials Group 307 Protocol Team2007 Jun 1J Acquir Immune Defic Syndr245
Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients.Velilla, P A ; Shata, M T ; Lages, C S ; Ying, J ; Fichtenbaum, C J ; Chougnet, C2008 JanAIDS Res Hum Retroviruses124
Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteers.Cao, Ying Jun ; Flexner, Charles W ; Dunaway, Shelia ; Park, Jeong-Gun ; Klingman, Karin ; Wiggins, Ilene ; Conley, Jeanne ; Radebaugh, Christine ; Kashuba, Angela D ; MacFarland, Ron ; Becker, Stephen ; Hendrix, Craig W2008 MayAntimicrob Agents Chemother552
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.Gandhi, Rajesh T ; Zheng, Lu ; Bosch, Ronald J ; Chan, Ellen S ; Margolis, David M ; Read, Sarah ; Kallungal, Beatrice ; Palmer, Sarah ; Medvik, Kathy ; Lederman, Michael M ; Alatrakchi, Nadia ; Jacobson, Jeffrey M ; Wiegand, Ann ; Kearney, Mary ; Coffin, John M ; Mellors, John W ; Eron, Joseph J ; AIDS Clinical Trials Group A5244 team2010PLoS Med87
Effect of raltegravir resistance mutations in HIV-1 integrase on viral fitness.Hu, Zixin ; Kuritzkes, Daniel R2010 OctJ Acquir Immune Defic Syndr255
Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.Overton, E T ; Kitch, D ; Benson, C A ; Hunt, P W ; Stein, J H ; Smurzynski, M ; Ribaudo, H J ; Tebas, P2013 MayClin Infect Dis1056
Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.Clifford, D B ; Smurzynski, M ; Park, L S ; Yeh, T-M ; Zhao, Y ; Blair, L ; Arens, M ; Evans, S R2009 Jul 28Neurology473
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.Smurzynski, Marlene ; Wu, Kunling ; Letendre, Scott ; Robertson, Kevin ; Bosch, Ronald J ; Clifford, David B ; Evans, Scott ; Collier, Ann C ; Taylor, Michael ; Ellis, Ronald2011 Jan 28AIDS325
Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.Blackard, Jason T ; Kang, Minhee ; Sherman, Kenneth E ; Koziel, Margaret James ; Peters, Marion G ; Chung, Raymond T2006 NovJ Interferon Cytokine Res1126
The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.Gupta, Samir K ; Smurzynski, Marlene ; Franceschini, Nora ; Bosch, Ronald J ; Szczech, Lynda A ; Kalayjian, Robert C ; AIDS Clinical Trials Group Longitudinal Linked Randomized Trials Study Team2009Antivir Ther414
Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.Mulligan, Kathleen ; Yang, Yang ; Wininger, David A ; Koletar, Susan L ; Parker, Robert A ; Alston-Smith, Beverly L ; Schouten, Jeffrey T ; Fielding, Roger A ; Basar, Michael T ; Grinspoon, Steven2007 Jan 2AIDS121
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients.Bedimo, Roger ; Kang, Minhee ; Tebas, Pablo ; Overton, Edgar T ; Hollabaugh, Kimberly ; McComsey, Grace ; Bhattacharya, Debika ; Evans, Christopher ; Brown, Todd T ; Taiwo, Babafemi2016 AprAIDS Res Hum Retroviruses432
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.Dubé, Michael P ; Parker, Robert A ; Mulligan, Kathleen ; Tebas, Pablo ; Robbins, Gregory K ; Roubenoff, Ronenn ; Grinspoon, Steven K2007 Jul 1Clin Infect Dis145
Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.Bhasin, Shalender ; Parker, Robert A ; Sattler, Fred ; Haubrich, Richard ; Alston, Beverly ; Umbleja, Triin ; Shikuma, Cecilia M ; AIDS Clinical Trials Group Protocol A5079 Study Team2007 MarJ Clin Endocrinol Metab392
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.Campbell, Thomas B ; Smeaton, Laura M ; Kumarasamy, N ; Flanigan, Timothy ; Klingman, Karin L ; Firnhaber, Cynthia ; Grinsztejn, Beatriz ; Hosseinipour, Mina C ; Kumwenda, Johnstone ; Lalloo, Umesh ; Riviere, Cynthia ; Sanchez, Jorge ; Melo, Marineide ; Supparatpinyo, Khuanchai ; Tripathy, Srikanth ; Martinez, Ana I ; Nair, Apsara ; Walawa2012PLoS Med89
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.Lennox, Jeffrey L ; Landovitz, Raphael J ; Ribaudo, Heather J ; Ofotokun, Ighovwerha ; Na, Lumine H ; Godfrey, Catherine ; Kuritzkes, Daniel R ; Sagar, Manish ; Brown, Todd T ; Cohn, Susan E ; McComsey, Grace A ; Aweeka, Francesca ; Fichtenbaum, Carl J ; Presti, Rachel M ; Koletar, Susan L ; Haas, David W ; Patterson, Kristine B ; Benson, 2014 Oct 7Ann Intern Med7161
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).Taiwo, Babafemi ; Zheng, Lu ; Gallien, Sebastien ; Matining, Roy M ; Kuritzkes, Daniel R ; Wilson, Cara C ; Berzins, Baiba I ; Acosta, Edward P ; Bastow, Barbara ; Kim, Peter S ; Eron, Joseph J ; ACTG A5262 Team2011 Nov 13AIDS1725
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.Grant, Philip M ; Komarow, Lauren ; Lederman, Michael M ; Pahwa, Savita ; Zolopa, Andrew R ; Andersen, Janet ; Asmuth, David M ; Devaraj, Sridevi ; Pollard, Richard B ; Richterman, Aaron ; Kanthikeel, Sudheesh ; Sereti, Irini2012 Dec 1J Infect Dis11206
Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia.Gallien, Sebastien ; Delaugerre, Constance ; Charreau, Isabelle ; Braun, Joséphine ; Boulet, Thomas ; Barrail-Tran, Aurélie ; de Castro, Nathalie ; Molina, Jean-Michel ; Kuritzkes, Daniel R2011 Mar 13AIDS525
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.Hosseinipour, Mina C ; Bisson, Gregory P ; Miyahara, Sachiko ; Sun, Xin ; Moses, Agnes ; Riviere, Cynthia ; Kirui, Fredrick K ; Badal-Faesen, Sharlaa ; Lagat, David ; Nyirenda, Mulinda ; Naidoo, Kogieleum ; Hakim, James ; Mugyenyi, Peter ; Henostroza, German ; Leger, Paul D ; Lama, Javier R ; Mohapi, Lerato ; Alave, Jorge ; Mave, Vidya ; V2016 Mar 19Lancet10024387
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.Torriani, Francesca J ; Komarow, Lauren ; Parker, Robert A ; Cotter, Bruno R ; Currier, Judith S ; Dubé, Michael P ; Fichtenbaum, Carl J ; Gerschenson, Mariana ; Mitchell, Carol K C ; Murphy, Robert L ; Squires, Kathleen ; Stein, James H ; ACTG 5152s Study Team2008 Aug 12J Am Coll Cardiol752
Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.Labo, Nazzarena ; Miley, Wendell ; Benson, Constance A ; Campbell, Thomas B ; Whitby, Denise2015 Jun 19AIDS1029
Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure.Sharkey, Mark ; Babic, Dunja Z ; Greenough, Thomas ; Gulick, Roy ; Kuritzkes, Daniel R ; Stevenson, Mario2011 FebPLoS Pathog27
Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapy.Schouten, Jeffrey Thomas ; Schiffer, Joshua T2012 May 1J Acquir Immune Defic Syndr160
European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.Hulgan, Todd ; Haubrich, Richard ; Riddler, Sharon A ; Tebas, Pablo ; Ritchie, Marylyn D ; McComsey, Grace A ; Haas, David W ; Canter, Jeffrey A2011 Jan 2AIDS125
Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095.Li, Li ; Eron, Joseph J ; Ribaudo, Heather ; Gulick, Roy M ; Johnson, Brent A2012J Am Stat Assoc498107
Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.Sattler, Fred R ; Rajicic, Natasa ; Mulligan, Kathleen ; Yarasheski, Kevin E ; Koletar, Susan L ; Zolopa, Andrew ; Alston Smith, Beverly ; Zackin, Robert ; Bistrian, Bruce ; ACTG 392 Study Team2008 NovAm J Clin Nutr588
Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption.Li, Jonathan Z ; Christensen, Julie A ; Wang, Hongying ; Spritzler, John ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5197 Study Team2012 Sep 1J Acquir Immune Defic Syndr161
Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.Luetkemeyer, Anne F ; Kendall, Michelle A ; Wu, Xingye ; Lourenço, Maria Cristina ; Jentsch, Ute ; Swindells, Susan ; Qasba, Sarojini S ; Sanchez, Jorge ; Havlir, Diane V ; Grinsztejn, Beatriz ; Sanne, Ian M ; Firnhaber, Cynthia ; Adult AIDS Clinical Trials Group A5255 Study Team2014 AprJ Clin Microbiol452
Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.Luetkemeyer, Anne F ; Firnhaber, Cynthia ; Kendall, Michelle A ; Wu, Xingye ; Mazurek, Gerald H ; Benator, Debra A ; Arduino, Roberto ; Fernandez, Michel ; Guy, Elizabeth ; Johnson, Pamela ; Metchock, Beverly ; Sattler, Fred ; Telzak, Edward ; Wang, Yun F ; Weiner, Marc ; Swindells, Susan ; Sanne, Ian M ; Havlir, Diane V ; Grinsztejn, Beat2016 May 1Clin Infect Dis962
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.Jacobson, Jeffrey M ; Pat Bucy, R ; Spritzler, John ; Saag, Michael S ; Eron, Joseph J ; Coombs, Robert W ; Wang, Rui ; Fox, Lawrence ; Johnson, Victoria A ; Cu-Uvin, Susan ; Cohn, Susan E ; Mildvan, Donna ; O'Neill, Dorothy ; Janik, Jennifer ; Purdue, Lynette ; O'Connor, Deborah K ; Vita, Christine Di ; Frank, Ian ; National Institute of 2006 Sep 1J Infect Dis5194
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.Henrich, Timothy J ; Tsibris, Athe M N ; Lewine, Nicolas R P ; Konstantinidis, Ioannis ; Leopold, Kay E ; Sagar, Manish ; Kuritzkes, Daniel R2010 DecJ Acquir Immune Defic Syndr455
Examining the challenges and solutions to the implementation of trials in resource-limited settings: Limited Resource Trials.Blanchard-Horan, Christina ; Stocker, Vicki ; Moran, Laura ; Ferguson, Elaine Okubo ; Klingman, Karin L ; McMahon, Deborah ; Hitti, Jane2012 Jan 1Appl Clin Trials121
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.Harrison, Taylor ; Miyahara, Sachiko ; Lee, Anthony ; Evans, Scott ; Bastow, Barbara ; Simpson, David ; Gilron, Ian ; Dworkin, Robert ; Daar, Eric S ; Wieclaw, Linda ; Clifford, David B ; ACTG A5252 Team2013 JulPain Med714
Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.Almeida, Coral-Ann M ; Roberts, Steven G ; Laird, Rebecca ; McKinnon, Elizabeth ; Ahmad, Imran ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Heckerman, David ; Mallal, Simon ; John, Mina2010 Aug 23Vaccine3728
Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.Chung, Raymond T ; Umbleja, Triin ; Chen, Jennifer Y ; Andersen, Janet W ; Butt, Adeel A ; Sherman, Kenneth E ; Actg A5178 Study Team2012 Mar-AprHIV Clin Trials213
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation.Dubé, Michael P ; Komarow, Lauren ; Fichtenbaum, Carl J ; Cadden, Joseph J ; Overton, Edgar T ; Hodis, Howard N ; Currier, Judith S ; Stein, James H ; AIDS Clinical Trials Group A5293 Study Team2015 Sep 1Clin Infect Dis561